Demis Hassabis, founder of DeepMind, has made a groundbreaking claim: advancements in AI, particularly with the AlphaFold2 model, could lead to the cure of all diseases within the next decade. This model has revolutionized drug discovery by mapping nearly 200 million known proteins, drastically reducing the time needed for research from years to hours.
Recent medical breakthroughs attributed to this technology include a drug that has doubled survival rates in pancreatic cancer, a gene-editing treatment that lowered bad cholesterol by 62%, and a new anti-obesity medication achieving a 30% weight loss in trials. Each of these innovations exemplifies the potential impact of AI on healthcare.
In financial markets, advanced AI applications are poised to redefine trading strategies. Louis Navellier, an investor with 47 years of experience, claims that the integration of AI into his stock-picking systems could significantly increase potential returns—up to 20 times more than traditional methods. His upcoming online event is set for June 10, 2024, where he will share insights on maximizing investment strategies using AI technology.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
